These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


611 related items for PubMed ID: 19140076

  • 1. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
    Larsen JK, Porsdal V, Aarre TF, Koponen HJ, Aarnio J, Kleivenes OK, Emblem Advisory Board.
    Nord J Psychiatry; 2009; 63(4):285-91. PubMed ID: 19140076
    [Abstract] [Full Text] [Related]

  • 2. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM advisory board.
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [Abstract] [Full Text] [Related]

  • 3. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
    Tohen M, Vieta E, Gonzalez-Pinto A, Reed C, Lin D, European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Advisory Board.
    J Clin Psychiatry; 2010 Mar; 71(3):255-61. PubMed ID: 19709503
    [Abstract] [Full Text] [Related]

  • 4. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
    Rosa AR, Cruz N, Franco C, Haro JM, Bertsch J, Reed C, Aarre TF, Sanchez-Moreno J, Vieta E.
    J Clin Psychiatry; 2010 Aug; 71(8):1000-6. PubMed ID: 20361912
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004.
    Wolfsperger M, Greil W, Rössler W, Grohmann R.
    J Affect Disord; 2007 Apr; 99(1-3):9-17. PubMed ID: 16989907
    [Abstract] [Full Text] [Related]

  • 6. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M, Mandelli L, Di Nicola M, Harnic D, Catalano V, Tedeschi D, Martinotti G, Colombo R, Bria P, Serretti A, Janiri L.
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [Abstract] [Full Text] [Related]

  • 7. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
    Vieta E, Panicali F, Goetz I, Reed C, Comes M, Tohen M, EMBLEM Advisory Board.
    J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
    [Abstract] [Full Text] [Related]

  • 8. Functional impairment in patients with mania: baseline results of the EMBLEM study.
    Goetz I, Tohen M, Reed C, Lorenzo M, Vieta E, EMBLEM Advisory Board.
    Bipolar Disord; 2007 Feb; 9(1-2):45-52. PubMed ID: 17391349
    [Abstract] [Full Text] [Related]

  • 9. The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy.
    Bellantuono C, Barraco A, Rossi A, Goetz I.
    BMC Psychiatry; 2007 Jul 19; 7():33. PubMed ID: 17640381
    [Abstract] [Full Text] [Related]

  • 10. Voluntary vs. involuntary hospital admission in acute mania of bipolar disorder: results from the Swiss sample of the EMBLEM study.
    Schuepbach D, Goetz I, Boeker H, Hell D.
    J Affect Disord; 2006 Jan 19; 90(1):57-61. PubMed ID: 16324749
    [Abstract] [Full Text] [Related]

  • 11. Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?
    Reed C, Novick D, Gonzalez-Pinto A, Bertsch J, Haro JM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun 15; 33(4):715-21. PubMed ID: 19345251
    [Abstract] [Full Text] [Related]

  • 12. [Management of patients with acute manic or mixed episodes and outcome at three months].
    Azorin JM, Luquiens A, Aubrun E, Reed C, Gasquet I, Lukasiewicz M.
    Encephale; 2010 Jun 15; 36(3):226-35. PubMed ID: 20620265
    [Abstract] [Full Text] [Related]

  • 13. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe.
    Cruz N, Vieta E, Comes M, Haro JM, Reed C, Bertsch J, EMBLEM Advisory Board.
    J Psychiatr Res; 2008 Oct 15; 42(13):1068-75. PubMed ID: 18262204
    [Abstract] [Full Text] [Related]

  • 14. Factors associated with pharmacologic noncompliance in patients with mania.
    Keck PE, McElroy SL, Strakowski SM, Stanton SP, Kizer DL, Balistreri TM, Bennett JA, Tugrul KC, West SA.
    J Clin Psychiatry; 1996 Jul 15; 57(7):292-7. PubMed ID: 8666570
    [Abstract] [Full Text] [Related]

  • 15. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
    Kim JH, Choi SW, Joe SH, Ha TH, Yoo HJ, Choi JE, Cha B, Ha K.
    Nord J Psychiatry; 2008 Jul 15; 62(6):496-502. PubMed ID: 18841509
    [Abstract] [Full Text] [Related]

  • 16. Chronic mania revisited: factors associated with treatment non-response during prospective follow-up of a large European cohort (EMBLEM).
    Van Riel WG, Vieta E, Martinez-Aran A, Haro JM, Bertsch J, Reed C, Van Os J.
    World J Biol Psychiatry; 2008 Jul 15; 9(4):313-20. PubMed ID: 18949649
    [Abstract] [Full Text] [Related]

  • 17. Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features.
    Craig TJ, Grossman S, Mojtabai R, Gibson PJ, Lavelle J, Carlson GA, Bromet EJ.
    Bipolar Disord; 2004 Oct 15; 6(5):406-15. PubMed ID: 15383133
    [Abstract] [Full Text] [Related]

  • 18. Determinants of voluntary vs. involuntary admission in bipolar disorder and the impact of adherence.
    Schuepbach D, Novick D, Haro JM, Reed C, Boeker H, Noda S, Angst J, Hell D, EMBLEM Advisory Board.
    Pharmacopsychiatry; 2008 Jan 15; 41(1):29-36. PubMed ID: 18203049
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacotherapy in bipolar disorder].
    Nolen WA.
    Ned Tijdschr Geneeskd; 1999 Jun 19; 143(25):1299-305. PubMed ID: 10416483
    [Abstract] [Full Text] [Related]

  • 20. Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM).
    Bellivier F, Yon L, Luquiens A, Azorin JM, Bertsch J, Gerard S, Reed C, Lukasiewicz M.
    Bipolar Disord; 2011 Jun 19; 13(4):377-86. PubMed ID: 21843277
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.